Co-Editor
- Professor of Medicine, University of California San Francisco (1992-2018)
- Professor of Medicine, Emeritus, University of California San Francisco (2018-Present)
- Chief of Infectious Diseases, San Francisco General Hospital (1992-2013)
- Director, UCSF Infectious Diseases Fellowship Training Program (2002-2013)
- Director, Clinical Research Services, Clinical & Translational Science Institute (2013-2020)
- Editor, American Society for Microbiology’s Antimicrobial Agents and Chemotherapy (2011-2018)
Area of Special Interest
-
Antimicrobial drug resistance, staphylococcal infections, experimental therapeutics and epidemiology and pathogenesis of disease caused by Staphylococcus aureus, mycobacterial infections, sepsis.
Professional Recognitions & Appointments
- Co-Chair, IDSA guidelines committee for Staphylococcal Bacteremia
- Fellow of the IDSA
- Fellow American College of Physicians
- Elected member of the American Society for Clinical Investigation
- Elected member of the Association of American Physicians
Publication Highlights
Over 300 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases including:
- Structural basis of broad-spectrum β-lactam resistance in Staphylococcus aureus. Nature - January 2023
- Prosthetic Valve Endocarditis Diagnosis and Management-New Paradigm Shift Narratives. Clinical Infectious Diseases - May 2021
- Skin and Soft Tissue Infections. Infectious Diseases Clinics of North America - March 2021
- Oral versus Intravenous Antibiotics for Endocarditis. New England Journal of Medicine - September 2021
- Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model. Journal of Antimicrobial Chemotherapy - September 2020
- Native-Valve Infective Endocarditis. The New England Journal of Medicine - August 2020
- Evaluation of a Paradigm Shift from Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review. JAMA Internal Medicine – May 2020.
- Omadacycline-The Newest Tetracycline. The New England Journal of Medicine - February 2019
- Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. Clinical Infectious Diseases - March 2018
- A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. New England Journal of Medicine - June 2017
- Antimicrobial Stewardship Approaches in the Intensive Care Unit. Infectious Disease Clinics of North America - September 2017
Education
- Centre College Kentucky (BA)
- Vanderbilt University (Medical School)
- University of California San Francisco, School of Medicine (Residency)
- University of California San Francisco, School of Medicine (Infectious Diseases Fellowship)
- Microbiology laboratory of Alexander Tomasz, Rockefeller University (Post-doctoral Fellowship)
Disclosures
- Moderna - Stock
- Merck - Stock, Member of Data Safety Monitoring Board
- Lilly - Medical Expert